Blue Jet Health (BLUEJET)
STALWARTFairStock Score: 64/100 — STEADY
Score breakdown: P/E: 1/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹413.75 |
| Market Cap | ₹7,030.55 Cr |
| P/E Ratio | 23.95 |
| ROCE | 39.75% |
| ROE | 25.91% |
| Dividend Yield | 0.3% |
| Profit Growth | 25.06% |
| Debt/Equity | 0.02 |
| Sales Growth | 20.56% |
| Free Cash Flow | ₹1,058 Cr |
| Promoter Holding | 79.81% |
| 52-Week Range | ₹325 — ₹1,027.8 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹65.32 |
Blue Jet Health trades with a P/E ratio of 23.95, ROCE of 39.75%, ROE of 25.91%, profit growth of 25.06%, debt-to-equity of 0.02. The FairStock Score of 64/100 suggests mixed fundamentals — some metrics look solid while others need improvement.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer